S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
J.B. Hunt Hits the Skids: Lower Prices to Come
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
J.B. Hunt Hits the Skids: Lower Prices to Come
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
J.B. Hunt Hits the Skids: Lower Prices to Come
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
J.B. Hunt Hits the Skids: Lower Prices to Come

HCA Healthcare (HCA) Stock Forecast & Price Target

$311.02
-2.87 (-0.91%)
(As of 04/17/2024 ET)

HCA Healthcare Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 15 Analyst Ratings

Analysts' Consensus Price Target

$314.05
0.98% Upside
High Forecast$359.00
Average Forecast$314.05
Low Forecast$265.00
TypeCurrent Forecast
4/19/23 to 4/18/24
1 Month Ago
3/20/23 to 3/19/24
3 Months Ago
1/19/23 to 1/19/24
1 Year Ago
4/19/22 to 4/19/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
10 Buy rating(s)
11 Buy rating(s)
16 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$314.05$308.26$297.00$271.45
Predicted Upside0.98% Upside13.10% Upside16.87% Upside13.87% Upside
Get HCA Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for HCA and its competitors with MarketBeat's FREE daily newsletter.

HCA Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HCA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

HCA Healthcare Stock vs. The Competition

TypeHCA HealthcareMedical CompaniesS&P 500
Consensus Rating Score
2.73
2.68
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside0.98% Upside934.30% Upside12.27% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/12/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$330.00 ➝ $359.00+11.73%
4/10/2024Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$335.00+2.12%
3/28/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$303.00 ➝ $315.00-5.17%
3/6/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$356.00+12.82%
1/31/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$320.00 ➝ $345.00+12.32%
1/31/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$308.00 ➝ $322.00+4.67%
1/31/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$300.00 ➝ $330.00+9.45%
1/17/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$315.00+12.29%
1/4/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform$277.00 ➝ $301.00+9.85%
12/11/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$271.00+5.23%
11/17/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$313.00 ➝ $265.00+7.34%
11/10/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$280.00+20.26%
10/25/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$325.00 ➝ $275.00+21.19%
10/25/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$324.00 ➝ $279.00+22.87%
7/28/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$311.00 ➝ $316.00+14.31%
6/28/20231-800-FLOWERS.COM
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
6/28/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
5/10/2023Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$285.00 ➝ $310.00+13.12%
4/24/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$325.00 ➝ $350.00+23.24%
4/24/2023Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$285.00 ➝ $320.00+13.79%
4/24/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$294.00 ➝ $323.00+14.86%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 09:16 AM ET.

HCA Price Target - Frequently Asked Questions

What is HCA Healthcare's consensus rating and price target?

According to the issued ratings of 15 analysts in the last year, the consensus rating for HCA Healthcare stock is Moderate Buy based on the current 4 hold ratings and 11 buy ratings for HCA. The average twelve-month price prediction for HCA Healthcare is $314.05 with a high price target of $359.00 and a low price target of $265.00. Learn more on HCA's analyst rating history.

Do Wall Street analysts like HCA Healthcare more than its competitors?

Analysts like HCA Healthcare more than other Medical companies. The consensus rating score for HCA Healthcare is 2.73 while the average consensus rating score for medical companies is 2.68. Learn more on how HCA compares to other companies.

Does HCA Healthcare's stock price have much upside?

According to analysts, HCA Healthcare's stock has a predicted upside of 11.32% based on their 12-month stock forecasts.

What analysts cover HCA Healthcare?

Stock Ratings Reports and Tools

This page (NYSE:HCA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners